What's Happening

You are here

[Issue No. 169] PSS E-Bulletin October 2020

DCH Auriga Singapore

Position Available: Patient Solutions Associate

The 2020 Guangdong Annual Pharmacy Congress, held on 24th October 2020, invited PSS to deliver a talk focusing on Hospital pharmacy leadership in Covid19 management.

In the month of October, Stroke Services Improvement (SSI), supported by the Ministry of Health (MOH), launched the 2020 National Stroke Awareness Campaign “Be Stroke Smart” - an evolution of the 2019 campaign to mitigate the new normal environment with the COVID-19 pandemic.

The Health Sciences Authority (HSA), in consultation with its Product Vigilance Advisory Committee (PVAC), would like to inform healthcare professionals of the new restriction on the use of montelukast due to the risk of neuropsychiatric events. This follows HSA’s benefit-risk assessment of montelukast which concluded that the benefits of montelukast for use in allergic rhinitis patients remain favourable if additional precautionary measures are put in place to mitigate the known but rare risk of neuropsychiatric events.